This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
QUICK READ: Recent research from Zoom Rx saying that digital interactions with HCPs are myopic and don’t apply to the heavily segmented HCP audience. Zoom Rx recently polled HCPs and found 78% of physicians want to maintain some contact with pharma reps. doctors and 45% of all NPS and physician assistants as verified members.
Pharmaceutical marketing budgets are going through a period of readjustment as companies explore and exploit a myriad of different digital channels to deliver content to, and engage with, their doctors and other audiences. You can view the Engaging Doctors Around the Globe whitepaper here or by clicking on the button above or below.
IN SUMMARY : When patients return to doctor’s offices will HCP’s have time to go online with every drug company that requests an online detail? Back to HCP’s…digitization can’t replace the relationships that pharma reps and MLS people build with doctors. As for patients?
Research has shown that 74% of all U.S. This is one area where pharmacompanies can restore trust and excel. . ” 42% of Americans research their doctor’s suggestions after a visit. Over 75% of Americans use social media to research their health symptoms. . Of those, 80% turn online to do so.
When it comes to pharma marketing, historically companies have had to either market direct to consumers — and trust them to find a doctor and bring up the company’s product with them — or to send sales reps to doctors — and hope they had the right mix of potential customers among their patients.
IN BRIEF: Pharmacompanies have been posting jobs on LinkedIn almost every day. While most offices remain closed pharma is preparing for the launch of new products and has to have the infrastructure to ensure a successful launch. They’re doing more online research and listening more to what other patients have to say.
First, people aren’t always completely honest with their doctors. A recent study published in the journal JAMA Network Open found that 60 to 80 percent of patients have been less than fully forthright with their doctors at some point which can be worse with telehealth. What can pharma do?
Yes, telehealth has grown substantially, but that’s because patients are afraid of going into doctor’s offices. Let’s be clear about pharma product websites. In a click-stream analysis earlier this year, I found that over 90% of online health seekers used other health websites to research treatments.
Medscape conducted some research in May to find out. Digital channels play a far greater role in communication between pharmacompanies and healthcare professionals than before the pandemic. . Of course Medscape used this research as a self-promotion to show increases in their online metrics. Medscape Detailed Findings.
SUMMARY: With patients staying away from their doctors because of COVID, DTC messages need to add incentives and better messaging to get people to take action rather than wait. My doctor’s office recently sent me an email that they had plenty of telehealth appointments available for patients who didn’t want to come to the office.
1ne: Pharmacompanies are forcing out older, experienced employees. 2wo: Talented marketing people don’t want to work in pharma because of the culture. 3hree: Pharma-only agencies have forced out people who created great campaigns and replaced them with people who are too anxious to make a name for themselves.
” 62% of physicians agree that the info pharmacompanies provide on third-party websites for healthcare professionals “are always ads” for their products, and only one in three (34%) trust the information pharmas provide on these websites. Manhatten Research Taking The Pulse 2017. But what about online? 2017 study.
They expect and want more from HCPs and pharmacompanies. 5ive: People are interacting with their doctors in new ways. There is no longer a need to go to the doctor to ask for an Rx renewal. They are also overwhelmed with data, and there are trust issues around the sources of data.
Pharmacompanies have been investing deeply into digital advertising but vastly under measuring customer engagement and other metrics. Pharma marketers spend countless hours developing PowerPoints and getting approval for tactics, but they need specific listening metrics to pivot quickly if their plans aren’t effective.
A year ago, Facebook was making a hard charge to get the pharma business. From my estimates, most of it failed because pharmacompanies are afraid of misinformation concerning regulations around DTC marketing.
SUMMARY: Doctors said they were dissatisfied were marketing emails (46%), telephone sales calls with sales reps (42%), and both webinars and websites (each at 39%) from pharmacompanies, according to Indegene. Also, one message to ALL doctors sold not make sense. 100 percent of U.S. 100 percent of U.S.
A sales representative for a biotech company shared information with oncologists about patients’ attitudes towards treatment options, including the company’s brand. The research showed that patients wanted to understand how the drug works and the potential side effects.
From an in-depth analysis of metrics for several clients, including research with audiences, DTC TV ads are doing a good job driving awareness. I have been developing, for clients, a patient journey map from awareness to asking for an Rx based on research with current customers. DTC managers are often surprised by the results.
81 percent of American adults have a smartphone, according to Pew Research but we must remember there is a huge difference between “health (wellness) apps and apps that focus on specific health conditions” The global mHealth app market is growing fast and expected to reach $111 billion by 2025. Blood sugar or diabetes tools.
But do doctors trust the system? healthcare system significantly declined during the pandemic , along with their confidence in the leaders and executives at the healthcare organizations employing them, according to a report from the nonpartisan research group NORC at the University of Chicago commissioned by the ABIM Foundation.
As part of our patient advocacy efforts, at FindMeCure we are dedicated to creating a bridge between patients and the world of clinical research. This includes spreading clinical trial awareness, connecting patients to the trials they are interested in but also speaking up about the issues in the clinical research industry. .
Doctors using telemedicine software are not sure of its value to patients and believe telehealth may pose risks. Back when everyone was afraid to go to a doctor’s office, I said that the use of telehealth would decline and level off. .” The hype around telehealth has followed a projected pattern. from 2020 to 2027.
SUMMARY : Falsehoods have been shown to spread faster and farther than accurate information, and research suggests that misinformation can have negative effects in the real world, such as amplifying controversy about vaccines and propagating unproven cancer treatments.
OPENING: Pharmacompanies are starting to embrace digital marketing forced, in large part, by changes brought on by the pandemic. Most HCPs said pharmacompanies are increasingly providing education on how to better treat patients remotely and help them manage their conditions in light of COVID-19.
This is partly due to the differing business models used by pharmacompanies and digital therapeutic developers. To do that, the company would need to do clinical research that features both therapies, he adds. According to Wasden, the interests of digital therapeutics developers and pharmacompanies can also clash.
Pharma, PBM, and health insurance CEOs earn hundreds of millions of dollars to do one thing; make their companies a lot of money. Government funding contributed to research associated with all 210 new drugs approved by the U.S. Rising costs are unsustainable despite the talk about virtual visits.
While the consolidation of agencies may be a priority for some pharmacompanies a good digital agency can add a lot of value. All of our agencies also had access to all of our research. QUICK READ: According to Setup 30% of Brand marketers say they’re likely/somewhat likely to switch Agencies in the next 6 months.
Pharmacompanies are increasing digital budgets, but they are wasting too much money because of internal staffing issues and inexperience with online marketing. Pharma continues to ignore a content strategy and the power to use content to be a leader in the health category. Challenge #1 – DIGITAL MARKETING.
The shift to virtual alone has already had a profound impact on all conference stakeholders: medical societies themselves, doctors, patients, commercial partners, and professional conference organisers (PCOs). Doctors want a choice. Part 2 will assess possible scenarios for 2022 and beyond. Lessons learnt 2020-2021. yes; and 15.7%
Apple’s latest ad campaign for its Apple Watch makes much of its ability to monitor health functions – but researchers are concerned it may encourage people to seek medical attention prematurely. That included six out of 21 patients (15%) who had received a specific alert from the Apple Watch, according to the researchers.
For their parts, patient advocates share survey results with drug companies or recruit patients and caregivers to speak about the nature of their diseases and existing treatments. Second—and closely related to the first transformation—patient centricity requires new kinds of relationships between industry and patient advocacy groups.
Speakers at the NIHR’s recent virtual event for the pharma industry discussed best practices for bringing patient insights into research. They’re not having to travel to speak to researchers in person anymore,” he said. Likewise, we’ve got greater flexibility in being able to do research at a time of their choosing.
billion for research into the disease, which represents a fraction of the overall spend dedicated to learning more about cancer’s development in humans and in the creation of new treatments. Research published this year suggests that the incidence of Europeans dying from cancer is likely to increase by 32% in 2040, compared to 2020.
There is hope among researchers and drug developers that hepatitis C treatment innovations can be leveraged to find a cure for hepatitis B. This may be due to lack of access or problems preventing patients from visiting doctors such as mistrust of healthcare systems or mental health issues. DOWNLOAD THE FULL ARTICLE HERE.
Cate Evans, SVP group director, strategy at Havas Media Group, and Nick Lapolla, research director at MedSurvey tell us about a two-phase research study the companies recently performed to understand a patient’s prescription journey and who influences prescription-based decisions. Influential individuals.
Ask a diabetes patient which pharmacompany is the leader in diabetes therapy? You’re likely to hear a whole range of answers because no company has moved forward with content that ensures they become the standard for online diabetes patients. 2wo: What’s the relationship between TV DTC and a product website?
Protas will design and run smart clinical trials through collaborations with charities, foundations, academic research teams and industry partners, and will take on both repurposed and experimental drugs. “It’s not about making money from the trials, it’s about driving public health benefit,” he told the BBC.
For 55% of pharma respondents and 47% of service providers, a contributing factor is their lack of insight into what HCPs actually value in terms of the content, channels, formats, etc. For those, EPG Health’s report , The Gaps Between HCP demand and Pharma Supply of Medical Information , will provide some answers.
(New York Times ) If you spend any time reading pharma PR releases, you’ll see over and over again corporate managements stressing the importance of the shareholder. When a new drug is derailed the first thing that pops out is the effect on the company’s stock price, not patients.
PCD Pharma Franchise is a popular business model. It is a business arrangement in which a pharmacompany offers the rights of marketing and distribution to its franchise partner. The pharmacompany thus expands its business and reaches new regions. You can ask the opinion of expert doctors as well.
The webinar discussed findings of exclusive surveys showing the continuing medical education (CME) needs of doctors and shone a light on where physicians are going for their learning needs amid the COVID-19 pandemic. He said: “They do have a responsibility towards educating healthcare professionals on the correct use of their drugs.”.
That’s where pharma market research comes in. Whether you’re launching a new drug or competing with established brands like Humira or Jardiance , market research provides the insights you need to succeed. But how exactly does pharma market research work, and why is it so essential for marketing professionals?
So, historically – certainly pre-2000 – if you look at the way prescription drugs were communicated, it was very tightly controlled: it was pharmacompanies speaking to doctors and the doctor would speak to the patient and tell them what they thought the right solution was,” he said.
The time of individuals relying entirely on face-to-face interaction with their doctors is long past. Although junior doctors may be more digitally native, it is possible that there will be more widespread adoption in experienced medical professionals, because they understand the medical and patient end value better.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content